Relaxin downregulates the calcium binding protein S100A4 in MDA-MB-231 human breast cancer cells

Annals of the New York Academy of Sciences

Volumn 1041, Issue , 2005, Pages 462-469

  Radestock, Yvonne ^a   Hoang Vu, Cuong ^b   Hombach Klonisch, Sabine ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Breast cancer; LGR7; Relaxin; Relaxin receptor; S100A4 metastasin

Indexed keywords

CALCIUM BINDING PROTEIN; CALVASCULIN; ENHANCED GREEN FLUORESCENT PROTEIN; ESTROGEN RECEPTOR ALPHA; HUMAN RELAXIN 2; MESSENGER RNA; PEPTIDE HORMONE; PROTEIN S 100; PROTEIN S100 A4; RELAXIN; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER CELL CULTURE; CONFERENCE PAPER; DOWN REGULATION; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HORMONE RELEASE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 23644433686     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1282.070     Document Type: Conference Paper

References (35)

1. SHERWOOD, O.D. 2004. Relaxin's physiological roles and other diverse actions. Endocr. Rev. 25: 205-234.
2. BATHGATE, R.A.D., C.S. SAMUEL, T.C.D. BURAZIN, et al. 2003 Relaxin: new peptides, receptors and novel actions. Trends Endocrinol. Metab. 14: 207-213.
3. IVELL, R. & A. EINSPANIER. 2002. Relaxin peptides are new global players. Trends Endocrinol. Metab. 13: 343-348.
4. HSU, S.Y., M. KUDO, T. CHEN, et al. 2000. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Molec. Endocrinol. 14: 1257-1271.
5. HSU, S.Y., K. NAKABAYSHI, S. NISHI, et al. 2002. Activation of orphan receptors by the hormone relaxin. Science 295: 671-674.
6. HSU, S.Y. 2003 New insights into the evolution of the relaxin-LGR signaling system. Trends Endocrinol. Metab. 14: 303-309.
7. BANI, G. & M. BIGAZZI. 1984. Morphological changes induced in mouse mammary gland by porcine and human relaxin. Acta Anat. (Basel) 119: 149-154.
8. BANI, G., M. BIGAZZI & D. BANI. 1985. Effects of relaxin on the mouse mammary gland. 1. The myoepithelial cells. J. Endocrinol. Invest. 8: 207-215.
9. KUENZI, M.J., B.A. CONNOLLY & O.D. SHERWOOD. 1995. Relaxin acts directly on rat mammary nipples to stimulate their growth. Endocrinology 136: 2943-2947.
10. ZHAO, L., P.J. ROCHE, J.M. GUNNERSEN, et al. 1999. Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 140: 445-453.
11. KRAJNC-FRANKEN, M.A., A.J. VAN DISSELDORP, J.E. KOENDERS, et al. 2004. Impaired nipple development and parturition in LGR7 knockout mice. Mol. Cell Biol. 24: 687-696.
12. TASHIMA, L.S., G. MAZOUJIAN & G.D. BRYANT-GREENWOOD. 1994. Human relaxins in normal, benign and neoplastic breast tissue. J. Mol. Endocrinol. 12: 351-364.
13. SILVERTOWN, J.D., B.J. GEDDES & A.J. SUMMERLEE. 2003. Adenovirus-mediated expression of human prorelaxin promotes the invasive potential of canine mammary cancer cells. Endocrinology 144: 3683-3691.
14. SILVERTOWN, J.D., A.J.S. SUMMERLEE & T. KLONISCH. 2003. Relaxin-like peptides in cancer. Int. J. Cancer 107: 513-519.
15. BINDER, C., T. HAGEMANN, B. HUSEN, et al. 2002. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Molec. Human Reprod. 8: 789-796.
16. BANI, D., D. FLAGIELLO, M.F. POUPON, et al. 1999. Relaxin promotes differentiation of human breast cancer cells MCF-7 transplanted into nude mice. Virchows Arch. 435: 509-519.
17. BIGAZZI, M., M.L. BRANDI, G. BANI & T. BANI SACCHI. 1992. Relaxin influences the growth of MCF-7 breast cancer cells. Mitogenic and antimitogenic action depends on peptide concentration. Cancer 70: 639-643.
18. PILLAI, S.B., C. ROCKWELL, O.D. SHERWOOD & R.D. Koos. 1999. Relaxin stimulates uterine edema via activation of estrogen receptors: blockade of its effects using ICI 182,780, a specific estrogen receptor antagonist. Endocrinology 14: 2426-2429.
19. BINDER, C., A. SIMON, L. BINDER, et al. 2004. Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients. Breast Cancer Res. Treat. 87: 157-166.
20. BELOT, N., R. POCHET, C.W. HEIZMANN, et al. 2002. Extracellular SIOOA4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. Biochim. Biophys. Acta 1600: 74-83.
21. SCHÄFER, B.W. & C.W. HEIZMANN. 1996. The S100 family of EF-hand calcium-binding protein: function and pathology. Trends Biochem. Sci. 21: 134-140.
22. JENKINSON, S.R., R. BARRACLOUGH, C.R. WEST & P.S. RUDLAND. 2004. S100A4 regulated cell motility and invasion in an in vitro model for breast cancer metastasis. Brit. J. Cancer 90: 253-262.
23. LLOYD, B.H., A. PLATT-HIGGINS, P.S. RUDLAND & R. Barraclough. 1998. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene 17: 465-473.
24. ZHANG, S., G. WANG, D.G. FERNIG, et al. 2005. Interaction of metastasis-inducing S100A4 protein in-vivo by fluorescence lifetime imaging microscopy. Eur. Biophys. J. 34: 19-27.
25. SCHMIDT-HANSEN, B., D. ORNAS, M. GRIGORIAN, et al. 2004. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 23: 5487-5495.
26. Li, Z.H., A. SPEKTOR, O. VARLAMOVA & A.R. BRESNICK. 2003. Mts1 regulates the assembly of nonmuscle myosin-HA. Biochemistry 42:14258-14266.
27. KIM, E.J. & D.M. HELFMAN. 2003. Characterization of the metastasis-associated protein, S100A4. Roles of calcium binding and dimerization in cellular localization and interaction with myosin. J. Biol. Chem. 278: 30063-30073.
28. SHERBET, G.V. & M.S. LAKSHMI. 1998. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis. Anticancer Res. 18: 2415-2421.
29. LEE, W.Y., W.C. SU, P.W. LIN, et al. 2004. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Oncology 66: 429-438.
30. SCHMIDT-HANSEN, B., J. KLINGELHOFER, B. GRUM-SCHWENSEN, et al. 2004 Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay. J. Biol. Chem. 279: 24498-24504.
31. GRIGORIAN, M., S. ANDRESEN, E. TULCHINSKY, et al. 2001. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J. Biol. Chem. 276: 22699-22708.
32. PEDERSON, K.B., K. ANDERSEN, O. FODSTAD & G.M. MAELANDSMO. 2004. Sensitizing of interferon-gamma induced apoptosis in human osteosarcoma cells by extracellular S100A4. BMC Cancer 4: 52.
33. EL NAAMAN, C., B. GRUM-SCHWENSEN, A. MANSOURI, et al. 2004. Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene. Oncogene 23: 3670-3680.
34. LEE, H.Y., S. ZHAO, P.A. FIELDS & O.D. SHERWOOD. 2005 The extend to which relaxin promotes proliferation and inhibits apoptosis of cervical epithelial and stromal cells is greatest during late pregnancy in rats. Endocrinology 146: 511-518.
35. SAMUEL, C.S., H. TIAN, L. ZHAO & E.P. AMANTO. 2003. Relaxin is a key mediator of prostate growth and male reproductive tract development. Lab. Invest. 83: 1055-1067.